This impact is underscored by preclinical studies in Parkinson’s, Alzheimer’s and other CNS disease where FGF21 promotes neuroprotection and mitigates neurodegeneration through effects on different cell populations which crossover to ALS [75–81]. The gene discussed is FGF21; the disease is Parkinson disease.